HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
about
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives.Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study.HER2 evaluation and its impact on breast cancer treatment decisions.Chemotherapy regimens in early breast cancer: major controversies and future outlook.Antisense oligodeoxynucleotide targeting HER2 mRNA sensitized docetaxel in breast cancer treatment.TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy.Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent.
P2860
Q33369478-4FF4E0FF-0B1F-45AB-8A56-099E05465C53Q34284284-FABB832B-68D8-410A-8DC4-2273D84F9069Q34713799-C76692EB-9D88-45E0-9015-1E66F06920D9Q35087728-76021B2C-1AA1-4525-B1B6-A72536C15523Q35576343-AFCCFE96-535E-496A-8958-5698824830B6Q38081243-FC63C496-856F-4976-9B4B-32CAEE56FA7FQ39455425-976B5A32-C1B7-40DC-9DFC-576AA9B5AE0DQ39574212-BF25B6AD-1A5B-4AC9-A1F6-B8ADFC121D44Q41234329-8B8EAE02-604A-4094-85E6-DDEE0DC8675B
P2860
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
HER2 expression and efficacy o ...... apy in breast cancer patients.
@ast
HER2 expression and efficacy o ...... apy in breast cancer patients.
@en
type
label
HER2 expression and efficacy o ...... apy in breast cancer patients.
@ast
HER2 expression and efficacy o ...... apy in breast cancer patients.
@en
prefLabel
HER2 expression and efficacy o ...... apy in breast cancer patients.
@ast
HER2 expression and efficacy o ...... apy in breast cancer patients.
@en
P2093
P2860
P356
P1476
HER2 expression and efficacy o ...... apy in breast cancer patients.
@en
P2093
A Lavarello
B Castagneto
G Cavazzini
L Del Mastro
L Perdelli
P2860
P2888
P356
10.1038/SJ.BJC.6602660
P407
P50
P577
2005-07-01T00:00:00Z
P5875
P6179
1047374811